About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNPhase 2NCT01634204

Efficacy of a Web-based Weight Loss Program

Since overweight and obesity, a risk factor for various diseases, is a prevalent problem in the modern society, it is important to search for new strategies to counteract this. In contrast to in perso...

Lead sponsor: Charite University, Berlin, Germany•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Charite University, Berlin, Germany

Collaborators

KiloCoach e.U.
University Hospital Regensburg

Age

30 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•age 30-65 years
•body Mass Index: 27-39,9 kg/m2
•ECOG-Performance status degree 0 or 1
•basal internet skills
•private internet access
•signed informed consent

Exclusion Criteria

•malign diseases
•major organ diseases
•inflammatory bowel diseases
•insulin - dependent diabetes mellitus
•pregnancy, breast feeding
•treatment of eating disorders (e.g. bulimia, anorexia nervosa) within past 5 years
•parallel participation in other weight loss programs or other trials
•weight loss \> 5% within past 6 month
•chronic therapy with glucocorticoids
•subjects treated because of psychiatric disorders (e.g. schizophrenia, bipolar disorder) in the past
•subjects with expected non-compliance to protocol guidelines

Related studies

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more

RECRUITINGPhase 3

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

NCT07595549 · Obesity, Overweight and/or Obesity, and more

RECRUITINGPhase 3

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

NCT06937086 · Ulcerative Colitis, Obesity or Overweight

RECRUITINGPhase 3

Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

NCT07284875 · Obesity, Overweight

Access to Kidney Transplant of Obese Patients Beginning Dialysis

NCT04748770 · Kidney Transplant Access, Obese Patients, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 6, 2012Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE2

Enrollment84

Start dateSep 2011

Last updatedJul 6, 2012

Condition

Overweight Obese

Locations shown

KiloCoach e.U.

Vienna

Charité- Universitätsmedizin Berlin

Berlin

University Hospital Regensburg

Regensburg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 6, 2012Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions